ARCHIVES

Amgen Halts Phase III Trial Of Ganitumab Plus Gemcitabine

This article is from The Cancer Letter archive.

Vol. 35 No. 8 | August 31, 2012

Download PDF Visit The Full Archive

Related Articles

Tivozanib Trumps Sorafenib In 1st-Line Renal Cancer Study

May 25, 2012

In Brief: Curt Appointment Now Official; Bipartisan Effort Seeks $150 Million FDA Budget Increase

April 21, 1989

Senate Outlines Budget Priorities In Bill Report

July 19, 1991

NCI Cooperative Group Clinical Trials Approved

May 29, 2009

In Brief: UK Scientist Receives Pezcoller Award; Yale Appoints Associate Director for Trials

January 19, 1996

In Brief: George Vande Woude To Wistar institute Board; Donald Pinkel To Head Pediatric Leukemia Program

October 18, 1985